J Korean Soc Transplant.  2009 Sep;23(2):149-153. 10.4285/jkstn.2009.23.2.149.

Comparison of New Onset Diabetes according to the Time of Onset in Kidney Transplant Recipients

• Yoon KJ
• Park JH
• Kim DJ
• Park SG
• Lee JH
• Kim JS
• Hyun SJ
• Lee S

• KMID: 2097082
• DOI: http://doi.org/10.4285/jkstn.2009.23.2.149

Abstract

BACKGROUND
New onset diabetes is a common complication after kidney transplantation. However, the clinical course of post-transplant diabetes mellitus (PTDM) remains unclear. The aim of the present study is to analyze the natural courses and risk factors of PTDM according to the time of onset.
METHODS
A total of 216 consecutive kidney transplant recipients were enrolled and patient medical records were investigated retrospectively. PTDM was defined as glucose > or =126mg without previous diabetic history. Patients were classified according to the onset (12 months): early PTDM (E-PTDM) and late PTDM (L-PTDM).
RESULTS
PTDM was observed in 34 (17.4%) patients. The number of E-PTDM and L-PTDM patients was 17 and 17. Compared with normoglycemic patients, the PTDM group was older and showed higher pre-transplant HbA1c level. The use of tacrolimus was associated with the development of E-PTDM (OR=4.87, 1.71~13.8 in 95% CI) but not L-PTDM (OR=0.34, 0.04~2.70 in 95% CI)
CONCLUSIONS
The development of E-PTDM and L-PTDM may have different risk factors. It will be important to choose different therapeutic strategy according to the onset of PTDM.

Keyword

Renal transplantation; Post-transplantation diabetes mellitus; Risk factor

MeSH Terms

Diabetes Mellitus
Glucose
Humans
Kidney
Kidney Transplantation
Medical Records
Retrospective Studies
Risk Factors
Tacrolimus
Transplants
Glucose
Tacrolimus

Reference

1). Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ. Diabetes mellitus after kidney transplantation in the united states. Am J Transplant. 2003; 3:178–85.

2). Davidson J, Wilkinson A, Dantal J, Dotta F, Haller H, Hernandez D, et al. International Expert Panel. New-on-set diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. Transplantation. 2003; 75(10S):3–24.

3). Kang J, Yu SB, Yun IJ, Lee TS, Chung IM, Chung JK, et al. Long-term outcomes of posttransplant diabetes mellitus in renal transplant recipients. J Korean Soc Transplant. 2005; 19:157–62.

4). Montori VM, Basu A, Erwin PJ, Velosa JA, Gabriel SE, Kudva YC. Posttransplantation diabetes: A systematic review of the literature. Diabetes Care. 2002; 25:583–92.

5). Kang J, Ha J, Park YJ, Lee T, Jung IM, Chung J, et al. Development and clinical implication of posttransplant diabetes mellitus. J Korean Soc Transplant. 2007; 21:262–8.

6). Hur KY, Kim MS, Kim YS, Kang ES, Nam JH, Kim SH, et al. Risk factors associated with the onset and progression of posttransplantation diabetes in renal allograft recipients. Diabetes Care. 2007; 30:609–15.

7). Hjelmesaeth J, Jenssen T, Hartmann A. Diagnosing PTDM. Transplantation. 2003; 75:1761.

8). American Diabetes Association. Diagnosis and classi-fication of diabetes mellitus. Diabetes Care. 2009; 32(S1):S62–7.

9). Cosio FG, Pesavento TE, Osei K, Henry ML, Ferguson RM. Posttransplant diabetes mellitus: Increasing incid-ence in renal allograft recipients transplanted in recent years. Kidney Int. 2001; 59:732–7.

10). Nam JH, Mun JI, Kim SI, Kang SW, Choi KH, Park K, et al. beta-Cell dysfunction rather than insulin resist-ance is the main contributing factor for the development of postrenal transplantation diabetes mellitus. Transplantation. 2001; 71:1417–23.

11). Kang WH, Kim MS, Ju MK, Chang HK, Ahn HJ, Kim SI, et al. Risk factors of posttransplantation diabetes mellitus in renal transplant recipients. J Korean Soc Transplant. 2007; 21:111–8.

12). Hjelmesaeth J, Hartmann A, Kofstad J, Stenstr⊘m J, Leivestad T, Egeland T, et al. Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age. Transplantation. 1997; 64:979–83.

13). Arner P, Gunnarsson R, Blomdahl S, Groth CG. Some characteristics of steroid diabetes: A study in renal-transplant recipients receiving high-dose corticosteroid therapy. Diabetes Care. 1983; 6:23–5.

14). Parikh CR, Klem P, Wong C, Yalavarthy R, Chan L. Obesity as an independent predictor of posttransplant diabetes mellitus. Transplant Proc. 2003; 35:2922–6.

15). Bonato V, Barni R, Cataldo D, Collini A, Ruggieri G, de Bartolomeis C, et al. Analysis of posttransplant diabetes mellitus prevalence in a population of kidney transplant recipients. Transplant Proc. 2008; 40:1888–90.

16). Saudek CD, Herman WH, Sacks DB, Bergenstal RM, Edelman D, Davidson MB. A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab. 2008; 93:2447–53.

17). Hoban R, Gielda B, Temkit M, Saha C, Book BK, Baker E, et al. Utility of HbA1c in the detection of subclinical post renal transplant diabetes. Transplantation. 2006; 81:379–83.